End-stage Renal Disease
📧 Sign up to get email alerts when something new happens for End-stage Renal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Intravenously to Healthy Adult Volunteers [Phase 1]
Phase 1 pharmacokinetics study of intravenous ferric pyrophosphate citrate (Triferic) in healthy adult volunteers related to End Stage Renal…
-
CLINICAL_TRIALS withdrawal · 2019-02-01Clinical Trial Update: Safety and Efficacy of Plant-based Diets in Hemodialysis Patients [NA]
An interventional trial evaluating plant-based diets in patients with end-stage renal disease on hemodialysis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM) [Phase 4]
Phase 4 trial update evaluating the efficacy and safety of an everolimus-based regimen in renal transplant recipients (TRANSFORM).
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Dialysis Performance of Different Dialyzer Membranes Using Different Coagulation Strategies [NA]
This clinical trial update notes the completion of a study comparing dialyzer membrane performance during hemodialysis using different coagu…
-
CLINICAL_TRIALS research · 2019-01-29Clinical Trial Update: Cessation of Dialysis Treatment in Reinbek and Geesthacht
This clinical trial update reports cessation of dialysis treatment in Reinbek and Geesthacht, linked to complications of renal dialysis and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2 in Hemodialysis Patients [Phase 4]
Clinical trial evaluating whether replacing warfarin with rivaroxaban, with or without vitamin K2, affects vascular calcification in hemodia…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: The ONE Study UK Treg Trial [Phase 1, Phase 2]
The ONE Study UK Treg Trial, a Phase 1/2 investigation of regulatory T cell therapy for end-stage renal disease, has completed its trials.
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis [Phase 1]
Phase 1 study of LY3113593 in healthy participants and in patients with chronic kidney disease on hemodialysis, with results posted in 2019.
-
CLINICAL_TRIALS withdrawal · 2019-01-17Clinical Trial Update: Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients [Phase 4]
A Phase 4 trial studying aspirin for prevention of cardiovascular events in patients with end-stage renal disease undergoing hemodialysis ha…
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Sodium Chloride and Protein-Bound Toxin Removal in Hemodiafiltration [NA]
The trial NCT01923961 evaluating sodium chloride and protein-bound toxin removal in hemodiafiltration for end-stage renal disease has comple…
-
CLINICAL_TRIALS trial_result · 2019-01-02Clinical Trial Update: The ONE Study ATDC Trial [Phase 1, Phase 2]
Phase 1/2 clinical trial update for the ATDC trial (ONE Study) completed, investigating treatment in renal failure, end stage renal disease.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Pentoxifylline and Systemic Inflammation in Hemodialysis Patients [Phase 4]
Phase 4 clinical trial update investigating pentoxifylline for systemic inflammation in hemodialysis patients has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients [Phase 4]
A Phase 4 clinical trial evaluating the use of telmisartan and captopril in inflammation among patients on hemodialysis with end-stage renal…
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Belatacept in Kidney Transplantation of Moderately Sensitized Patients [Phase 4]
A Phase 4 clinical trial evaluating belatacept in moderately sensitized kidney transplant patients has been withdrawn.
-
FDA approval · 2018-11-20FDA Approved: CALCIUM ACETATE — Supplemental Application (Chartwell RX, LLC.)
FDA approved a supplemental application for Calcium Acetate from Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2018-11-06Clinical Trial Update: Effects of Mesna on Homocysteine in Kidney Failure [Phase 2]
Phase 2 trial update examining the effect of mesna on homocysteine levels in patients with end-stage renal disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Data Collection for Next Generation Ultrasound Technology Development [NA]
Clinical trial update indicating completed data collection for next-generation ultrasound technology development; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-30Clinical Trial Update: TARGTEPO Treatment for Anemia in Chronic Kidney Disease (CKD) Patients and End-Stage Renal Disease (ESRD) [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating TARGTEPO for anemia in chronic kidney disease and end-stage renal disease; results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: Triferic Pediatric Pharmacokinetic Protocol [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial update for Triferic pediatric pharmacokinetics.
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Treatment Modification to Reduce Symptom Burden in Hemodialysis [NA]
Clinical trial update on treatment modification to reduce symptom burden in patients undergoing hemodialysis.
-
CLINICAL_TRIALS trial_result · 2018-09-07Clinical Trial Update: Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation [Phase 1, Phase 2]
Phase 1/2 trial evaluating immune globulin plus rituximab for desensitization in highly HLA-sensitized patients awaiting deceased donor kidn…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury [Phase 2]
Phase 2 clinical trial update on using eculizumab to prevent and treat kidney graft reperfusion injury in patients with end-stage renal dise…
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: Phosphodiesterase Type 5 Inhibition to Improve Endothelial Function and Vascular Remodeling in Chronic Kidney Disease and End Stage Renal Disease Patients Requiring New Arteriovenous Fistula [NA]
A completed clinical trial evaluating phosphodiesterase type 5 inhibition to improve endothelial function and vascular remodeling in chronic…
-
CLINICAL_TRIALS trial_result · 2018-08-14Clinical Trial Update: Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation [Phase 4]
Phase 4 trial assessing sodium bicarbonate 8.4% solution as a catheter lock to prevent lumen clotting and catheter loss in hemodialysis pati…
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions [NA]
Clinical trial update on a specialized community disease management program aimed at reducing substance use and hospital readmissions; resul…